• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,470.11 -238.41
( -0.31%)
Global Indices
Nasdaq
51,860.73 -306.69
(-0.59%)
Dow Jones
7,464.20 -14.49
(-0.19%)
Hang Seng
66,064.76 1,923.64
(3.00%)
Nikkei 225
10,542.79 -57.58
(-0.54%)
Forex
USD-INR
96.42 0.06
(0.07%)
EUR-INR
110.27 -0.10
(-0.09%)
GBP-INR
129.65 -0.46
(-0.35%)
JPY-INR
0.59 0.00
(-0.05%)

EQUITY - MARKET SCREENER

Manappuram Finance Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
531213
INE522D01027
169.6677815
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MANAPPURAM
20.79
31702.59
EPS(TTM)
Face Value()
Div & Yield %
16.23
2
0.74
 

Fischer Medical Ventures reports consolidated net loss of Rs 7.10 crore in the March 2026 quarter
May 30,2026
Net loss of Fischer Medical Ventures reported to Rs 7.10 crore in the quarter ended March 2026 as against net profit of Rs 1.31 crore during the previous quarter ended March 2025. Sales rose 98.76% to Rs 97.73 crore in the quarter ended March 2026 as against Rs 49.17 crore during the previous quarter ended March 2025.

For the full year,net profit rose 2463.64% to Rs 31.02 crore in the year ended March 2026 as against Rs 1.21 crore during the previous year ended March 2025. Sales rose 178.75% to Rs 308.58 crore in the year ended March 2026 as against Rs 110.70 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales97.7349.17 99 308.58110.70 179
OPM %1.025.08 -13.963.00 -
PBDT-1.332.43 PL 49.564.34 1042
PBT-2.251.92 PL 46.582.71 1619
NP-7.101.31 PL 31.021.21 2464